CSL Behring

Groundbreaking Gene Therapy Treatment for Haemophilia B Introduced to NHS

Groundbreaking gene therapy treatment for haemophilia B has been introduced to the NHS, offering hope to patients like Elliott Collins. Elliott, who relied on regular injections for nearly three decades, has seen a significant improvement in his condition with the innovative therapy. This breakthrough in gene therapy provides new hope for individuals with haemophilia B, potentially offering an alternative to regular injections and improving their quality of life.